Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 427

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 427
---
 equivalents       |     |                    2,729 |   |     |  (67,946 | ) |     |            (56,289 | ) |     |    (37,362 | ) |
| Cash and cash equivalents at end of the period                |     |                    4,638 |   |     |    6,883 |   |     |             41,727 |   |     |     48,836 |   |

Net cash used in operating activities Net cash used in operating activities decreased by $40,428, or 4.7%, from $856,861 for the six months ended December31, 2023, to $816,433 for the six months ended December31, 2024. This decrease was primarily driven by a lower use of cash in working capital, particularly due to a mainly due to lower inventory purchases and accounts receivable collections, which generated $78,551 of cash during the period, compared to the absorption of $386,134 in the prior year. Additionally, non -cashitems such as higher amortization of intangible assets and stock -basedcompensation contributed to narrowing the net loss but had limited influence on operating cash flows, which remained primarily driven by changes in working capital. Net cash used in operating activities increased by $579,190, or 44.3%, from $1,306,705 for the year ended June 30, 2023, to $1,885,895 for the year ended June 30, 2024. This increase was primarily due to changes in working capital, which included a $571,592 increase in inventories. This inventory buildup was strategically undertaken to meet expected demand and to mitigate potential supply chain risks and the possible adverse effects of economic policy changes during the period. To enhance liquidity, the Company also discounted deferred checks through financial institutions, primarily received from related parties for the sale of Heritas Diagnostics services. The Company continues to recognize the receivables and the amount received from the financial institution is recorded as a financial liability, and the cash received is classified as a financing cash inflow. When the cash is collected by the financial institution, the liability and the receivables are de -recognised. This transaction is reflected in the cash flow statement as an operating cash inflow for the reduction of the accounts receivable, and a financial cash outflow for the cancellation of the financial debt. Net cash generated from / (used in) investing activities Net cash generated from/(used in